PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 23857473-8 2013 In contrast, JNK-specific inhibition, by SP600125, triggered upregulation of DR4 and DR5, and sensitized SK-Hep1 cells to TRAIL, indicating that the CAPE-induced suppression of JNK may contribute to the sensitizing effect of CAPE through the upregulation of death receptors. pyrazolanthrone 41-49 TNF receptor superfamily member 10a Homo sapiens 77-80 30317758-11 2018 Blocking JNK pathway by SP600125, the expression of DR4 and DR5 decreased (P < 0.05), Bax expression decreased and Bcl2 expression increased compared with HNK+TRAIL group. pyrazolanthrone 24-32 TNF receptor superfamily member 10a Homo sapiens 52-55 26822174-6 2016 Antioxidant N-acetyl-L-cysteine (NAC) and c-Jun NH2-terminal kinase (JNK) inhibitor SP600125 inhibited PEITC-induced DR4 and DR5 expression. pyrazolanthrone 84-92 TNF receptor superfamily member 10a Homo sapiens 117-120 23007278-8 2012 Pretreatment with the c-Jun N-terminal kinase (JNK) inhibitor SP600125 and the reactive oxygen species (ROS) scavenger N-acetylcysteine reduced the SVT and TRAIL-induced upregulation of DR4 and DR5 expression, expression of the apoptosis related protein such as caspase-3 and-9, as well as cell growth inhibitory effects. pyrazolanthrone 62-70 TNF receptor superfamily member 10a Homo sapiens 186-189 18645026-7 2008 Pretreatment with an antioxidant (N-acetylcysteine) or a c-Jun NH(2)-terminal kinase inhibitor (SP600125) effectively prevented Andro-induced p53 activation and DR4 up-regulation and eventually blocked the Andro-induced sensitization on TRAIL-induced apoptosis. pyrazolanthrone 96-104 TNF receptor superfamily member 10a Homo sapiens 161-164